Cardium Therapeutics, Inc. (CXM) Posts Q2 Loss of 37c/Share
Cardium Therapeutics, Inc. (AMEX: CXM) reported Q2 EPS of ($0.37) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
